{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:48:19Z","timestamp":1792784899349,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tri-Service Nursing Research Program Grant N16-P14"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Ketamine is a multimodal dissociative anesthetic, which provides powerful analgesia for victims with traumatic injury. However, the impact of ketamine administration in the peri-trauma period on the development of post-traumatic stress disorder (PTSD) remains controversial. Moreover, there is a major gap between preclinical and clinical studies because they utilize different doses and routes of ketamine administration. Here, we investigated the effects of sub-anesthetic doses of intravenous (IV) ketamine infusion on fear memory and brain glucose metabolism (BGluM) in rats. Male Sprague-Dawley rats received an IV ketamine infusion (0, 2, 10, and 20\u2009mg\/kg, 2\u2009h) or an intraperitoneal (IP) injection (0 and 10\u2009mg\/kg) following an auditory fear conditioning (3 pairings of tone and foot shock [0.6\u2009mA, 1\u2009s]) on day 0. Fear memory retrieval, fear extinction, and fear recall were tested on days 2, 3, and 4, respectively. The effects of IV ketamine infusion (0 and 10\u2009mg\/kg) on BGluM were measured using\n                    <jats:sup>18<\/jats:sup>\n                    F-fluoro-deoxyglucose positron emission tomography (FDG-PET) and computed tomography (CT). The IV ketamine infusion dose-dependently enhanced fear memory retrieval, delayed fear extinction, and increased fear recall in rats. The IV ketamine (10\u2009mg\/kg) increased BGluM in the hippocampus, amygdala, and hypothalamus, while decreasing it in the cerebellum. On the contrary, a single ketamine injection (10\u2009mg\/kg, IP) after fear conditioning facilitated fear memory extinction in rats. The current findings suggest that ketamine may produce differential effects on fear memory depending on the route and duration of ketamine administration.\n                  <\/jats:p>","DOI":"10.1038\/s41398-018-0310-8","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T05:27:49Z","timestamp":1543555669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Enhanced fear memories and brain glucose metabolism (18F-FDG-PET) following sub-anesthetic intravenous ketamine infusion in Sprague-Dawley rats"],"prefix":"10.1038","volume":"8","author":[{"given":"Kennett D.","family":"Radford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Y.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongna","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Knutsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Osborne-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Dardzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang H.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"key":"310_CR1","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1365-2044.2008.05835.x","volume":"64","author":"C Morris","year":"2009","unstructured":"Morris, C., Perris, A., Klein, J. & Mahoney, P. Anaesthesia in haemodynamically compromised emergency patients: does ketamine represent the best choice of induction agent? Anaesthesia 64, 532\u2013539 (2009).","journal-title":"Anaesthesia"},{"key":"310_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/749837","volume":"2015","author":"BM Radvansky","year":"2015","unstructured":"Radvansky, B. M. et al. Role of ketamine in acute postoperative pain management: a narrative review. Biomed. Res. Int. 2015, 1\u201310 (2015).","journal-title":"Biomed. Res. Int."},{"key":"310_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal, J. H. et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans - psychotomimetic, perceptual, cognitive, and neuroendocrine response. Arch. Gen. Psychiatry 51, 199\u2013214 (1994).","journal-title":"Arch. Gen. Psychiatry"},{"key":"310_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065088","volume":"8","author":"PR Corlett","year":"2013","unstructured":"Corlett, P. R. et al. Ketamine effects on memory reconsolidation favor a learning model of delusions. PLoS ONE 8, e65088 (2013).","journal-title":"PLoS ONE"},{"key":"310_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.neuropharm.2011.02.023","volume":"62","author":"T Jovanovic","year":"2012","unstructured":"Jovanovic, T., Kazama, A., Bachevalier, J. & Davis, M. Impaired safety signal learning may be a biomarker of PTSD. Neuropharmacology 62, 695\u2013704 (2012).","journal-title":"Neuropharmacology"},{"key":"310_CR6","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychological Association.","year":"2013","unstructured":"American Psychological Association. Diagnostic and Statistical Manual of Mental Disorders. 5th edn, (American Psychiatric Publishing, Washington, DC, 2013).","edition":"5th edn"},{"key":"310_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.nlm.2016.09.016","volume":"136","author":"M Wicking","year":"2016","unstructured":"Wicking, M. et al. Deficient fear extinction memory in posttraumatic stress disorder. Neurobiol. Learn. Mem. 136, 116\u2013126 (2016).","journal-title":"Neurobiol. Learn. Mem."},{"key":"310_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neulet.2016.11.064","volume":"649","author":"LA Averill","year":"2017","unstructured":"Averill, L. A. et al. Glutamate dysregulation and glutamatergic therapeutics for PTSD: evidence from human studies. Neurosci. Lett. 649, 147\u2013155 (2017).","journal-title":"Neurosci. Lett."},{"key":"310_CR9","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam, B., Adams, B., Verma, A. & Daly, D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 17, 2921\u20132927 (1997).","journal-title":"J. Neurosci."},{"issue":"8 Suppl","key":"310_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.7205\/MILMED-D-13-00481","volume":"179","author":"LL McGhee","year":"2014","unstructured":"McGhee, L. L. et al. The intraoperative administration of ketamine to burned U.S. service members does not increase the incidence of post-traumatic stress disorder. Mil. Med. 179(8 Suppl), 41\u201346 (2014).","journal-title":"Mil. Med."},{"key":"310_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/0269881107082481","volume":"22","author":"M Schonenberg","year":"2008","unstructured":"Schonenberg, M., Reichwald, U., Domes, G., Badke, A. & Hautzinger, M. Ketamine aggravates symptoms of acute stress disorder in a naturalistic sample of accident victims. J. Psychopharmacol. 22, 493\u2013497 (2008).","journal-title":"J. Psychopharmacol."},{"key":"310_CR12","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1111\/anae.14079","volume":"72","author":"G Mion","year":"2017","unstructured":"Mion, G., Le Masson, J., Granier, C. & Hoffmann, C. A retrospective study of ketamine administration and the development of acute or post-traumatic stress disorder in 274 war-wounded soldiers. Anaesthesia 72, 1476\u20131483 (2017).","journal-title":"Anaesthesia"},{"key":"310_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/0269881107082481","volume":"22","author":"M Schonenberg","year":"2008","unstructured":"Schonenberg, M., Reichwald, U., Domes, G., Badke, A. & Hautzinger, M. Ketamine aggravates symptoms of acute stress disorder in a naturalistic sample of accident victims. J. Psychopharmacol. 22, 493\u2013497 (2008).","journal-title":"J. Psychopharmacol."},{"key":"310_CR14","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1176\/appi.ajp.161.12.2194","volume":"161","author":"H Winter","year":"2004","unstructured":"Winter, H. & Irle, E. Hippocampal volume in adult burn patients with and without posttraumatic stress disorder. Am. J. Psychiatry 161, 2194\u20132200 (2004).","journal-title":"Am. J. Psychiatry"},{"key":"310_CR15","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00213-014-3697-9","volume":"232","author":"LM Zhang","year":"2015","unstructured":"Zhang, L. M. et al. Anxiolytic effects of ketamine in animal models of posttraumatic stress disorder. Psychopharmacol. (Berl.) 232, 663\u2013672 (2015).","journal-title":"Psychopharmacol. (Berl.)"},{"key":"310_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2016.12.026","volume":"100","author":"MJ Girgenti","year":"2017","unstructured":"Girgenti, M. J., Ghosal, S., LoPresto, D., Taylor, J. R. & Duman, R. S. Ketamine accelerates fear extinction via mTORC1 signaling. Neurobiol. Dis. 100, 1\u20138 (2017).","journal-title":"Neurobiol. Dis."},{"key":"310_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.euroneuro.2013.08.007","volume":"24","author":"A Juven-Wetzler","year":"2014","unstructured":"Juven-Wetzler, A. et al. Immediate ketamine treatment does not prevent posttraumatic stress responses in an animal model for PTSD. Eur. Neuropsychopharmacol. 24, 469\u2013479 (2014).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"310_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/(SICI)1520-6394(1997)5:1<29::AID-DA5>3.0.CO;2-0","volume":"5","author":"JS Silvestre","year":"1997","unstructured":"Silvestre, J. S., Nadal, R., Pallares, M. & Ferre, N. Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar rats. Depress Anxiety 5, 29\u201333 (1997).","journal-title":"Depress Anxiety"},{"key":"310_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bbr.2017.04.048","volume":"329","author":"M Morena","year":"2017","unstructured":"Morena, M. et al. Effects of ketamine, dexmedetomidine and propofol anesthesia on emotional memory consolidation in rats: consequences for the development of post-traumatic stress disorder. Behav. Brain. Res. 329, 215\u2013220 (2017).","journal-title":"Behav. Brain. Res."},{"key":"310_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neulet.2017.08.026","volume":"658","author":"L Saur","year":"2017","unstructured":"Saur, L. et al. Ketamine promotes increased freezing behavior in rats with experimental PTSD without changing brain glucose metabolism or BDNF. Neurosci. Lett. 658, 6\u201311 (2017).","journal-title":"Neurosci. Lett."},{"issue":"Pt A","key":"310_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pbb.2015.10.013","volume":"139","author":"CM Groeber Travis","year":"2015","unstructured":"Groeber Travis, C. M., Altman, D. E. & Genovese, R. F. Ketamine administration diminishes operant responding but does not impair conditioned fear. Pharmacol. Biochem. Behav. 139(Pt A), 84\u201391 (2015).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"310_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/0269881117748903","volume":"32","author":"NE Clifton","year":"2018","unstructured":"Clifton, N. E., Thomas, K. L. & Hall, J. The effect of ketamine on the consolidation and extinction of contextual fear memory. J. Psychopharmacol. 32, 156\u2013162 (2018).","journal-title":"J. Psychopharmacol."},{"key":"310_CR23","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/npp.2017.19","volume":"42","author":"JC McGowan","year":"2017","unstructured":"McGowan, J. C. et al. Prophylactic ketamine attenuates learned fear. Neuropsychopharmacology 42, 1577\u20131589 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"310_CR24","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-3565(25)30447-7","volume":"196","author":"MP Marietta","year":"1976","unstructured":"Marietta, M. P., White, P. F., Pudwill, C. R., Way, W. L. & Trevor, A. J. Biodisposition of ketamine in the rat: self-induction of metabolism. J. Pharmacol. Exp. Ther. 196, 536 (1976).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"310_CR25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000321803","volume":"63","author":"T Palenicek","year":"2011","unstructured":"Palenicek, T. et al. Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics. Neuropsychobiology 63, 202\u2013218 (2011).","journal-title":"Neuropsychobiology"},{"key":"310_CR26","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/00000542-197310000-00003","volume":"39","author":"ML Cohen","year":"1973","unstructured":"Cohen, M. L., Chan, S. L., Way, W. L. & Trevor, A. J. Distribution in the brain and metabolism of ketamine in the rat after intravenous administration. Anesthesiology 39, 370\u2013376 (1973).","journal-title":"Anesthesiology"},{"key":"310_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.pbb.2016.12.014","volume":"153","author":"KD Radford","year":"2017","unstructured":"Radford, K. D. et al. Dose-response characteristics of intravenous ketamine on dissociative stereotypy, locomotion, sensorimotor gating, and nociception in male Sprague-Dawley rats. Pharmacol. Biochem. Behav. 153, 130\u2013140 (2017).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"310_CR28","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.biopsych.2013.02.008","volume":"73","author":"PJ Carlson","year":"2013","unstructured":"Carlson, P. J. et al. Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study. Biol. Psychiatry 73, 1213\u20131221 (2013).","journal-title":"Biol. Psychiatry"},{"key":"310_CR29","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/0269881114568041","volume":"29","author":"N Lally","year":"2015","unstructured":"Lally, N. et al. Neural correlates of change in major depressive disorder anhedonia following open-label ketamine. J. Psychopharmacol. 29, 596\u2013607 (2015).","journal-title":"J. Psychopharmacol."},{"key":"310_CR30","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1176\/ajp.154.6.805","volume":"154","author":"A Breier","year":"1997","unstructured":"Breier, A., Malhotra, A. K., Pinals, D. A., Weisenfeld, N. I. & Pickar, D. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am. J. Psychiatry 154, 805\u2013811 (1997).","journal-title":"Am. J. Psychiatry"},{"key":"310_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0924-977X(96)00039-9","volume":"7","author":"FX Vollenweider","year":"1997","unstructured":"Vollenweider, F. X. et al. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). Eur. Neuropsychopharmacol. 7, 9\u201324 (1997).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"310_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/00000542-198206000-00005","volume":"56","author":"G Crosby","year":"1982","unstructured":"Crosby, G., Crane, A. M. & Sokoloff, L. Local changes in cerebral glucose utilization during ketamine anesthesia. Anesthesiology 56, 437\u2013443 (1982).","journal-title":"Anesthesiology"},{"key":"310_CR33","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.biopsych.2012.10.012","volume":"73","author":"NS Burghardt","year":"2013","unstructured":"Burghardt, N. S., Sigurdsson, T., Gorman, J. M., McEwen, B. S. & LeDoux, J. E. Chronic antidepressant treatment impairs the acquisition of fear extinction. Biol. Psychiatry 73, 1078\u20131086 (2013).","journal-title":"Biol. Psychiatry"},{"key":"310_CR34","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/ejn.13542","volume":"45","author":"TY Park","year":"2017","unstructured":"Park, T. Y. et al. Effects of isoflurane anesthesia and intravenous morphine self\u2010administration on regional glucose metabolism ([18F]FDG\u2010PET) of male Sprague\u2010Dawley rats. Eur. J. Neurosci. 45, 922\u2013931 (2017).","journal-title":"Eur. J. Neurosci."},{"key":"310_CR35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.pbb.2015.09.021","volume":"138","author":"PL Johnson","year":"2015","unstructured":"Johnson, P. L. et al. Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioning. Pharmacol. Biochem. Behav. 138, 174\u2013179 (2015).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"310_CR36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/0269881107077716","volume":"21","author":"PR Corlett","year":"2007","unstructured":"Corlett, P. R., Honey, G. D. & Fletcher, P. C. From prediction error to psychosis: ketamine as a pharmacological model of delusions. J. Psychopharmacol. 21, 238\u2013252 (2007).","journal-title":"J. Psychopharmacol."},{"key":"310_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pbb.2013.05.005","volume":"109","author":"SE Kotermanski","year":"2013","unstructured":"Kotermanski, S. E., Johnson, J. W. & Thiels, E. Comparison of behavioral effects of the NMDA receptor channel blockers memantine and ketamine in rats. Pharmacol. Biochem. Behav. 109, 67\u201376 (2013).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"310_CR38","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0278-5846(03)00080-0","volume":"27","author":"A Becker","year":"2003","unstructured":"Becker, A. et al. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 687\u2013700 (2003).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"310_CR39","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/ilar.52.3.366","volume":"52","author":"KA Trujillo","year":"2011","unstructured":"Trujillo, K. A. et al. The neurobehavioral pharmacology of ketamine: implications for drug abuse, addiction, and psychiatric disorders. ILAR J 52, 366\u2013378 (2011).","journal-title":"ILAR J"},{"key":"310_CR40","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.brainresbull.2006.01.010","volume":"69","author":"G Imre","year":"2006","unstructured":"Imre, G., Fokkema, D. S., Boer, J. A. D. & Ter Horst, G. J. Dose\u2013response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity. Brain Res. Bull. 69, 338\u2013345 (2006).","journal-title":"Brain Res. Bull."},{"key":"310_CR41","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/0091-3057(85)90291-6","volume":"22","author":"BE Hetzler","year":"1985","unstructured":"Hetzler, B. E. & Swain Wautlet, B. Ketamine-induced locomotion in rats in an open-field. Pharmacol. Biochem. Behav. 22, 653\u2013655 (1985).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"310_CR42","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.neuroscience.2010.03.032","volume":"167","author":"BK Goulart","year":"2010","unstructured":"Goulart, B. K. et al. Ketamine impairs recognition memory consolidation and prevents learning-induced increase in hippocampal brain-derived neurotrophic factor levels. Neuroscience 167, 969\u2013973 (2010).","journal-title":"Neuroscience"},{"key":"310_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejphar.2011.12.021","volume":"677","author":"M Moosavi","year":"2012","unstructured":"Moosavi, M., Yadollahi Khales, G., Rastegar, K. & Zarifkar, A. The effect of sub-anesthetic and anesthetic ketamine on water maze memory acquisition, consolidation and retrieval. Eur. J. Pharmacol. 677, 107\u2013110 (2012).","journal-title":"Eur. J. Pharmacol."},{"key":"310_CR44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.schres.2015.02.009","volume":"164","author":"MJ Honsberger","year":"2015","unstructured":"Honsberger, M. J., Taylor, J. R. & Corlett, P. R. Memories reactivated under ketamine are subsequently stronger: a potential pre-clinical behavioral model of psychosis. Schizophr. Res. 164, 227\u2013233 (2015).","journal-title":"Schizophr. Res."},{"key":"310_CR45","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1037\/0735-7044.110.3.618","volume":"110","author":"JD Baker","year":"1996","unstructured":"Baker, J. D. & Azorlosa, J. L. The NMDA antagonist MK-801 blocks the extinction of pavlovian fear conditioning. Behav. Neurosci. 110, 618\u2013620 (1996).","journal-title":"Behav. Neurosci."},{"key":"310_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007548","volume":"4","author":"JL Liu","year":"2009","unstructured":"Liu, J.-L. et al. A NMDA receptor antagonist, MK-801 impairs consolidating extinction of auditory conditioned fear responses in a Pavlovian model. PLoS ONE 4, e7548 (2009).","journal-title":"PLoS ONE"},{"key":"310_CR47","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bbr.2011.10.050","volume":"227","author":"M Pollard","year":"2012","unstructured":"Pollard, M. et al. Synaptic transmission changes in fear memory circuits underlie key features of an animal model of schizophrenia. Behav. Brain. Res. 227, 184\u2013193 (2012).","journal-title":"Behav. Brain. Res."},{"key":"310_CR48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.31887\/DCNS.2011.13.4\/mdavis","volume":"13","author":"M Davis","year":"2011","unstructured":"Davis, M. NMDA receptors and fear extinction: implications for cognitive behavioral therapy. Dialog. Clin. Neurosci. 13, 463\u2013474 (2011).","journal-title":"Dialog. Clin. Neurosci."},{"key":"310_CR49","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2478\/v10153-011-0068-8","volume":"53","author":"DP Getova","year":"2011","unstructured":"Getova, D. P. & Doncheva, N. D. Effects of ketamine on memory and nociception in rats. Folia Med. 53, 53\u201359 (2011).","journal-title":"Folia Med."},{"key":"310_CR50","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.2967\/jnumed.116.173443","volume":"57","author":"Y Zhu","year":"2016","unstructured":"Zhu, Y. et al. PET mapping of neurofunctional changes in a posttraumatic stress disorder model. J. Nucl. Med. 57, 1474\u20131477 (2016).","journal-title":"J. Nucl. Med."},{"key":"310_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2016.12.026","volume":"100","author":"MJ Girgenti","year":"2017","unstructured":"Girgenti, M. J., Ghosal, S., LoPresto, D., Taylor, J. R. & Duman, R. S. Ketamine accelerates fear extinction via mTORC1 signaling. Neurobiol. Dis. 100, 1\u20138 (2017).","journal-title":"Neurobiol. Dis."},{"key":"310_CR52","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/aps.2016.5","volume":"37","author":"M Gao","year":"2016","unstructured":"Gao, M., Rejaei, D. & Liu, H. Ketamine use in current clinical practice. Acta Pharmacol. Sin. 37, 865\u2013872 (2016).","journal-title":"Acta Pharmacol. Sin."},{"key":"310_CR53","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/bja\/50.9.885","volume":"50","author":"AE Waterman","year":"1978","unstructured":"Waterman, A. E. & Livingston, A. Effects of age and sex on ketamine anaesthesia in the rat. Br. J. Anaesth. 50, 885 (1978).","journal-title":"Br. J. Anaesth."},{"key":"310_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuropharm.2012.12.009","volume":"70","author":"N Carrier","year":"2013","unstructured":"Carrier, N. & Kabbaj, M. Sex differences in the antidepressant-like effects of ketamine. Neuropharmacology 70, 27\u201334 (2013).","journal-title":"Neuropharmacology"},{"key":"310_CR55","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuroscience.2015.01.008","volume":"290","author":"A Franceschelli","year":"2015","unstructured":"Franceschelli, A., Sens, J., Herchick, S., Thelen, C. & Pitychoutis, P. M. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naive and \u201cdepressed\u201d mice exposed to chronic mild stress. Neuroscience 290, 49\u201360 (2015).","journal-title":"Neuroscience"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-018-0310-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-018-0310-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-018-0310-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T07:33:16Z","timestamp":1775287996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-018-0310-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["310"],"URL":"https:\/\/doi.org\/10.1038\/s41398-018-0310-8","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]},"assertion":[{"value":"4 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"263"}}